Craniometaphyseal dysplasia: Ophthalmic features and management

Journal of Pediatric Ophthalmology and Strabismus

Volumn 40, Issue 4, 2003, Pages 228-231

  Puri, P ^a   Chan, J ^b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; CALCITONIN; CALCIUM;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BONE DYSPLASIA; CALCIUM INTAKE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE; CRANIOMETAPHYSEAL DYSPLASIA; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FAMILY HISTORY; FEMALE; HUMAN; HYPERMETROPIA; MALE; NERVE COMPRESSION; OPHTHALMOLOGY; OPTIC NERVE; PRESCHOOL CHILD; VISUAL ACUITY;

EID: 0037766482     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: 10.3928/0191-3913-20030701-12     Document Type: Article

References (6)

1. Colavita N, Kozlowski K, Sprague P. Craniometaphyseal dysplasia: report of 3 cases - two infants and one adult. Australas Radiol 1998;32:257-262.
2. Yamamoto T, Kurihara N, Yamaoka K, et al. Bone marrow-derived osteoclast-like cells from a patient with craniometaphyseal dysplasia lack expression of osteoclast-reactive vacuolat proton pump. J Clin Invest 1993;91:362-367.
3. Satoh K, Iwata T, Ikeda H. Unsuccessful consequence of optic canal decompression for a case of craniometaphyseal dysplasia. Plast Reconstr Surg 1994;94:705-707.
4. Richards A, Brain C, Dillon MJ, Bailey CM. Craniometaphyseal and craniodiaphyseal dysplasia: head and neck manifestations and management. J Laryngol Otol 1996;110:328-338.
5. Fanconi S, Fischer JA, Wieland P, Giedion A, Boltshauser E, Olah AJ. Craniometaphyseal dysplasia with increased bone turnover and secondary hypetpatathyroidism: therapeutic effect of calcitonin. J Pediatr 1998;4:587-591.
6. Cole DEC, Cohen MM. A new look at craniometaphyseal dysplasia. J Pediatr 1998;4:577-578.